Gastroenterology
Volume 138, Issue 4 , Pages 1276-1285 , April 2010

Genetic Approaches to Functional Gastrointestinal Disorders

  • Yuri A. Saito

      Affiliations

    • C.E.N.T.E.R., Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Nandita Mitra

      Affiliations

    • Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Emeran A. Mayer

      Affiliations

    • Center for Neurobiology of Stress, Division of Digestive Diseases, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California
    • Corresponding Author InformationReprint requests Address requests for reprints to: Emeran A. Mayer, MD, Center for Neurobiology of Stress, University of California, Los Angeles, 10945 Le Conte Avenue, Suite 2338, Room F, Los Angeles, California 90095-6949. fax: (310) 206-3343

References 

  1. Mayer EA, Bushnell MC. Functional pain disorders: time for a paradigm shift. In:  Mayer EA,  Bushnell MC editor. Functional pain syndromes: presentation and pathophysiology. Seattle, WA: IASP Press; 2009;p. 531–565
  2. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491
  3. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122:1778–1783
  4. Diatchenko L, Nackley AG, Slade GD, et al. Idiopathic pain disorders—pathways of vulnerability. Pain. 2006;123:226–230
  5. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of chronic pain condition. Hum Mol Genet. 2005;14:135–143
  6. Halder SL, Locke GR, Schleck CD, et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007;133:799–807
  7. Kalantar JS, Locke GR, Zinsmeister AR, et al. Familial aggregation of irritable bowel syndrome: a prospective study. Gut. 2003;52:1703–1707
  8. Saito YA, Zimmerman JM, Harmsen WS, et al. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil. 2008;20:790–797
  9. Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001;121:799–804
  10. Camilleri M, Carlson P, Zinsmeister AR, et al. Neuropeptide s receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders. Gastroenterology. 2010;138:98–107
  11. Papathanasopoulos A, Camilleri M, Carlson PJ, et al. A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity. Obesity (Silver Spring). 2009 Oct 29;[Epub ahead of print]
  12. Murphy DL, Lesch KP. Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci. 2008;9:85–96
  13. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397–414
  14. Hariri AR, Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci. 2006;10:182–191
  15. Cohen H, Buskila D, Neumann L, et al. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum. 2002;46:845–847
  16. Offenbaecher M, Bondy B, de Jonge S, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 1999;42:2482–2488
  17. Diatchenko L, Nackley AG, Slade GD, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain. 2006;125:216–224
  18. Van Kerkhoven LA, Laheij RJ, Jansen JB. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:979–986
  19. Gottesman , Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636–645
  20. Mayer EA. The challenge of studying the biology of complex, symptom-based GI disorders. Gastroenterology. 2008;134:1826–1827
  21. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci. 2006;7:818–827
  22. Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val 158 met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003;299:1240–1243
  23. Camilleri M, Busciglio I, Carlson P, et al. Candidate adrenergic, GNB3, and serotonergic polymorphisms, endophenotype, pharmacogenetics of clonidine in irritable bowel syndrome and health. Gastroenterology. 2008;
  24. Labus JS, Mayer EA, Hamaguchi T, et al. 5-Httlpr gene polymorphism modulates activity and connectivity within an emotional arousal network of healthy control subjects during visceral pain (abstr). Gastroenterology. 2008;134:A121
  25. Fukudo S, Kanazawa M, Mizuno T, et al. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage. 2009;47:946–951
  26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological). 1995;57:12
  27. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904–909
  28. Li Q, Yu K. Improved correction for population stratification in genome-wide association studies by identifying hidden population structures. Genet Epidemiol. 2008;32:215–226
  29. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389
  30. Fish EW, Shahrokh D, Bagot R, et al. Epigenetic programming of stress responses through variations in maternal care. Ann N Y Acad Sci. 2004;1036:167–180
  31. Cornelissen LL, Brooks DP, Wibberley A. Female, but not male, serotonin reuptake transporter (5-HTT) knockout mice exhibit bladder instability. Auton Neurosci. 2005;122:107–110
  32. Goldstein DB. Common genetic variation and human traits. N Engl J Med. 2009;360:1696–1698
  33. Papp J, Sobel E. The genetics of pain. In:  Mayer EA,  Bushnell MC editor. Functional pain syndromes: presentation and pathophysiology. Seattle, WA: IASP Press; 2009;p. 405–422
  34. Ioannidis JP, Thomas G, Daly MJ. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet. 2009;10:318–328
  35. Martin LJ, North KE, Dyer T, et al. Phenotypic, genetic, and genome-wide structure in the metabolic syndrome. BMC Genet. 2003;4(Suppl 1):S95
  36. Aukes MF, Alizadeh BZ, Sitskoorn MM, et al. Genetic overlap among intelligence and other candidate endophenotypes for schizophrenia. Biol Psychiatry. 2009;65:527–534
  37. Schaid DJ, Rowland CM, Tines DE, et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70:425–434
  38. Lake SL, Lyon H, Tantisira K, et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered. 2003;55:56–65
  39. Conti DV, Cortessis V, Molitor J, et al. Bayesian modeling of complex metabolic pathways. Hum Hered. 2003;56:83–93
  40. Kooperberg C, Ruczinski I. Identifying interacting SNPs using Monte Carlo logic regression. Genet Epidemiol. 2005;28:157–170
  41. Satagopan JM, Yandell BS, Newton MA, et al. A bayesian approach to detect quantitative trait loci using Markov chain Monte Carlo. Genetics. 1996;144:805–816
  42. Kesh S, Mensah NY, Peterlongo P, et al. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci. 2005;1062:95–103
  43. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69:138–147
  44. Chatterjee N, Kalaylioglu Z, Moslehi R, et al. Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions. Am J Hum Genet. 2006;79:1002–1016
  45. Rusk N. Focus on next-generation sequencing data analysis (Foreword). Nat Methods. 2009;6:S1
  46. Medvedev P, Stanciu M, Brudno M. Computational methods for discovering structural variation with next-generation sequencing. Nat Methods. 2009;6:S13–S20
  47. Li B, Leal SM. Discovery of rare variants via sequencing: implications for the design of complex trait association studies. PLoS Genet. 2009;5:e1000481
  48. Stephens M, Balding DJ. Bayesian statistical methods for genetic association studies. Nat Rev Genet. 2009;10:681–690
  49. Whorwell PJ, McCallum M, Creed FH, et al. Non-colonic features of irritable bowel syndrome. Gut. 1986;27:37–40
  50. Bellentani S, Baldoni P, Petrella S, et al. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room (The Local IBS Study Group). Fam Pract. 1990;7:307–312
  51. Locke GR, Zinsmeister AR, Talley NJ, et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000;75:907–912
  52. Levy RL, Whitehead WE, Von Korff MR, et al. Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol. 2000;95:451–456
  53. Kanazawa M, Endo Y, Whitehead WE, et al. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci. 2004;49:1046–1053
  54. Pata C, Erdal ME, Derici E, et al. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol. 2002;97:1780–1784
  55. Kim HJ, Camilleri M, Carlson PJ, et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004;53:829–837
  56. Yeo A, Boyd P, Lumsden S, et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut. 2004;53:1452–1458
  57. Lee DY, Park H, Kim WH, et al. Serotonin transporter gene polymorphism in healthy adults and patients with irritable bowel syndrome [in Korean]. Korean J Gastroenterol. 2004;43:18–22
  58. Park JM, Choi MG, Park JA, et al. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol Motil. 2006;18:995–1000
  59. Saito YA, Locke GR, Zimmerman JM, et al. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil. 2007;19:465–470
  60. Li Y, Nie Y, Xie J, et al. The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci. 2007;52:2942–2949
  61. Sikander A, Rana S, Sinha S, et al. Serotonin transporter promoter variant: Analysis in Indian IBS patients and control population. J Clin Gastroenterol. 2009;43:902–904
  62. Niesler B, Kapeller J, Fell C, et al. 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex. Eur J Gastroenterol Hepatol. 2009 Jun 25;[Epub ahead of print]
  63. Kohen R, Jarrett ME, Cain KC, et al. The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome. Dig Dis Sci. 2009 Jan 1;[Epub ahead of print]
  64. Saito Y, Larson J, Atkinson E, et al. The role of 5-HTT LPR and GNbeta3 825C>T polymorphisms and gene environment interactions in irritable bowel syndrome. Gastroenterology. 2009;136:289
  65. Pata C, Erdal E, Yazc K, et al. Association of the -1438 G/A and 102 T/C polymorphism of the 5-Ht2A receptor gene with irritable bowel syndrome 5-Ht2A gene polymorphism in irritable bowel syndrome. J Clin Gastroenterol. 2004;38:561–566
  66. Kapeller J, Houghton L, Monnikes H, et al. First evidence for an association of functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet. 2008;17:2967–2977
  67. Kapeller J, Houghton L, Walstab J, et al. A coding variant in the serotonin receptor 3C subunit is associated with diarrhea-predominant irritable bowel syndrome (abstr). Gastroenterology. 2009;136:A155–A156
  68. Gonsalkorale WM, Perrey C, Pravica V, et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?. Gut. 2003;52:91–93
  69. van der Veek P, de Kroon Y, Verspaget H, et al. Tumor necrosis factor alpha and interleukin 10 gene polymorphisms in irritable bowel syndrome (abstr). Gastroenterology. 2004;126:A53
  70. Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin Chim Acta. 2009;403:47–55
  71. Holtmann G, Siffert W, Haag S, et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology. 2004;126:971–979
  72. Andresen V, Camilleri M, Kim HJ, et al. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders?. Gastroenterology. 2006;130:1985–1994
  73. Colucci R, Ghisu N, Bellini M, et al. Analysis of cholecystokinin type 1 receptor gene polymorphisms in patients with irritable bowel syndrome (abstr). Gastroenterology. 2009;136:A225
  74. Saito YA, Strege PR, Tester DJ, et al. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol. 2009;296:G211–G218
  75. Villani A, Saito Y, Lemire M, et al. Validation of genetic risk factors for post-infectious irritable bowel syndrome (IBS) in patients with sporadic IBS. Gastroenterology. 2009;136:289

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by a grant from the National Institutes of Health (DK76797 to Y.A.S.) and (DK48351, DK64539, and AT002681 to E.A.M.).

PII: S0016-5085(10)00265-9

doi: 10.1053/j.gastro.2010.02.037

Gastroenterology
Volume 138, Issue 4 , Pages 1276-1285 , April 2010

Article Tools

* Image Usage & Resolution